Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jan;172(1):146-55.
doi: 10.2353/ajpath.2008.070690. Epub 2007 Dec 21.

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

John S Tzartos  1 , Manuel A Friese, Matthew J Craner, Jackie Palace, Jia Newcombe, Margaret M Esiri, Lars Fugger
Affiliations

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

John S Tzartos et al. Am J Pathol. 2008 Jan.

Abstract

Recent findings in the animal model for multiple sclerosis (MS), experimental autoimmune encephalomyelitis, implicate a novel CD4+ T-cell subset (TH17), characterized by the secretion of interleukin-17 (IL-17), in disease pathogenesis. To elucidate its role in MS, brain tissues from patients with MS were compared to controls. We detected expression of IL-17 mRNA (by in situ hybridization) and protein (by immunohistochemistry) in perivascular lymphocytes as well as in astrocytes and oligodendrocytes located in the active areas of MS lesions. Further, we found a significant increase in the number of IL-17+ T cells in active rather than inactive areas of MS lesions. Specifically, double immunofluorescence showed that IL-17 immunoreactivity was detected in 79% of T cells in acute lesions, 73% in active areas of chronic active lesions, but in only 17% of those in inactive lesions and 7% in lymph node control tissue. CD8+, as well as CD4+, T cells were equally immunostained for IL-17 in MS tissues. Interestingly, and in contrast to lymph node T cells, no perivascular T cells showed FoxP3 expression, a marker of regulatory T cells, at any stage of MS lesions. These observations suggest an enrichment of both IL-17+CD4+ and CD8+ T cells in active MS lesions as well as an important role for IL-17 in MS pathogenesis, with some remarkable differences from the experimental autoimmune encephalomyelitis model.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IL-17 mRNA expression in chronic active MS lesions. A: Low magnification with light microscopy of IL-17 mRNA expression in a chronic active lesion visualized by in situ hybridization with a specific probe for IL-17. Dotted line denotes the edge of an active border. B–D: High-magnification images of IL-17 mRNA expression in the active area of MS lesions with perivascular cells consistent with T cells [arrowhead in B and in high magnification (see inset)], parenchymal cells with astrocytic morphology (arrowhead in C) and cells with characteristic oligodendrocyte sizes and locations (arrowheads in D), all showing evidence of IL-17 mRNA expression. E: Negative control using the sense IL-17 riboprobe on a consecutive section counterstained with toluene blue (arrow in E). The figure shows that IL-17+ cells are located predominantly at the active border of a chronic active lesion (right side of dotted line in A), and that T cells (B), astrocytes (C), and oligodendrocytes (D) express IL-17 mRNA. Scale bars = 30 μm.
Figure 2
Figure 2
IL-17 production in inflammatory and glial cells in active areas of MS lesions. Double-immunofluorescence staining analyzed by confocal microscopy. Staining for IL-17 (A, D, G, and J; green), CD3 (B; for T cells, red), MHC class II (E; macrophages/microglia, red), GFAP (H; astrocytes, red), or CAII (K; oligodendrocytes, red) taken from active areas of an MS lesion. Overlays demonstrate expression of IL-17 in T cells (C; arrowhead demonstrates IL-17+ T cells, arrows demonstrate T cells negative for IL-17), astrocytes (I; arrowheads), and in oligodendrocytes (L; arrowheads), but not in macrophages/microglia, which are IL-17-negative (F; arrows). Scale bars = 10 μm.
Figure 3
Figure 3
IL-17 immunohistochemistry in perivascular cuffs from lesions with different activity. Light microscopic analysis of A, C, E, G, I, and K: CD3 immunostaining on consecutive sections. B, D, F, and H: IL-17 immunostaining in perivascular cells in MS lesions of different activity. A and B: Acute lesion. C and D: Active border of a chronic active lesion. E and F: Inactive center of a chronic active lesion. B, D, and F: The fibrillary staining beyond the perivascular spaces represents immunostaining for IL-17 in the processes of astrocytes. G and H: An inactive lesion is shown. I and J: CD3 and IL-17 immunostaining in NAWM from a case of MS. K and L: CD3 and IL-17 immunostaining in control brain. The figure shows more IL-17+ perivascular cells in the active (B and D) than the inactive (F and H) areas of the lesions. Arrowheads in B and D indicate abundance of IL-17 cells, whereas J and L indicate sparse IL-17+ cells. All sections were counterstained with hematoxylin. Scale bar = 30 μm.
Figure 4
Figure 4
Density of IL-17+ T cells in MS lesions of different activity. Quantitative analysis of perivascular CD3+ (A) and IL-17+ (B) T-cell density in areas of MS lesions with different activity, in NAWM, and in control brain. Histograms demonstrate a significantly higher density of T cells (A) and IL-17+ T cells (B) within perivascular active areas (acute lesions/active border of chronic active lesions) than in inactive lesions/inactive areas of chronic active lesions or NAWM and control tissue (n = 4). In contrast, there is no significant difference in the density of IL-17+ T cells within inactive areas and control tissue. The proportion of T cells that are IL-17+ was significantly higher in active than inactive areas of chronic active lesions (P = 0.0005).
Figure 5
Figure 5
IL-17+ in CD4+ and in CD8+ T cells. Confocal microscopy, high-magnification image from an inflammatory cuff, demonstrating a single cell. A and D: IL-17 staining (green); B: CD4 staining (red); E: CD8 staining (red). C and F: Overlays show production of IL-17 in CD4+ T cells (arrowhead in C, yellow) and in CD8+ T cells (arrowhead in F, yellow). G: Bars demonstrate higher frequency of IL-17+ both in CD4+ and CD8+ T-cell subsets within active lesions and in active borders of chronic active lesions. In contrast, in inactive areas of inactive and chronic active lesions there is a very low frequency of IL-17+ CD4+ (P = 0.002) and CD8+ (P = 0.03) T cells. Scale bar = 10 μm.
Figure 6
Figure 6
FoxP3+ T cells are absent in MS lesions. Double-immunofluorescent staining, analyzed by confocal microscopy. A, D, G, and J: staining for CD3 (red) and B, E, H, and K: FoxP3 (blue). C, F, and I: Overlays demonstrate that FoxP3 is not expressed in CD3+ cells in perivascular cuffs from acute (C) and inactive (F) MS lesions and control brain (I). L: Overlay demonstrates in lymph nodes that some T cells express FoxP3. M: IL-17+ (green) and N: FoxP3+ (blue) cells. O: Overlay demonstrates absence of FoxP3 expression from IL-17+ cells (arrowheads demonstrate IL-17+ cells and arrows demonstrate FoxP3+ cells). Scale bar = 10 μm.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005;23:683–747. - PubMed
    1. Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol. 1990;8:579–621. - PubMed
    1. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233–240. - PMC - PubMed
    1. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445:648–651. - PubMed
    1. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L, Shevach EM, O’Shea JJ. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 2007;26:371–381. - PubMed

Publication types